GNUbiotics Sciences SA

About

Company description

GNUbiotics Sciences, a Swiss biotech created in September 2016, is a privately funded company active in R&D to reproduce the natural diversity and complexity of unique structures found in mothers milk that are beneficial in preventing infections and onset of diet induced obesity. Building on exclusive rights from patents issued to Stanford University and own IP the company is developing a novel platform for selective microbiota modulation via natural mechanism of action with next generation Human Milk Oligosaccharides (HMOs) mimic composed of up to 130 diverse Microbiota Accessible Carbohydrates (MACs) structures. The company has a rich pipeline in nutrition (Pet and Infant) and later for medical food solutions. Short-term goal is to address the Pet Food market and hit the commercialization with a functional ingredient in Europe in 2019.